HOPEWELL, N.J. — BeiGene, a global biotech firm that develops cancer medicines, has opened a 400,000-square-foot life sciences facility in Hopewell, a suburb of Trenton. The manufacturing and ...

ImmunityBio shares were up 14% to $3.52 after the company entered into a collaboration and supply agreement with BeiGene. The two companies will conduct a confirmatory randomized Phase 3 clinical ...

With the business potentially at an important milestone, we thought we'd take a closer look at BeiGene, Ltd.'s... BeiGene stock just hit that mark, with a jump from 69 to 84 Wednesday. Is BeiGene ...

In a report released yesterday, Kelly Shi from Jefferies reiterated a Buy rating on BeiGene (ONC – Research Report), with a price target of $286.00. Kelly Shi’s rating is based on a ...